Efficacy of Tumor-Targeting <i>Salmonella typhimurium</i> A1-R against Malignancies in Patient-Derived Orthotopic Xenograft (PDOX) Murine Models
We developed tumor-targeting <i>Salmonella typhimurium</i> (<i>S. typhimurium</i>) A1-R, a facultative anaerobe that is an auxotroph of leucine and arginine. The tumor-targeting efficacy of <i>S. typhimurium</i> A1-R was demonstrated in vivo and vitro using severa...
Main Authors: | Takashi Murakami, Yukihiko Hiroshima, Kentaro Miyake, Tasuku Kiyuna, Itaru Endo, Ming Zhao, Robert M. Hoffman |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/8/6/599 |
Similar Items
-
Patient-Derived Orthotopic Xenograft (PDOX) Models of Melanoma
by: Robert M. Hoffman
Published: (2017-08-01) -
Trabectedin arrests a doxorubicin-resistant PDGFRA-activated liposarcoma patient-derived orthotopic xenograft (PDOX) nude mouse model
by: Tasuku Kiyuna, et al.
Published: (2018-08-01) -
The combination of gemcitabine and docetaxel arrests a doxorubicin-resistant dedifferentiated liposarcoma in a patient-derived orthotopic xenograft model
by: Kentaro Miyake, et al.
Published: (2019-09-01) -
Resveratrol and Its Nanoformulation Attenuate Growth and the Angiogenesis of Xenograft and Orthotopic Colon Cancer Models
by: Thangirala Sudha, et al.
Published: (2020-03-01) -
Patient-Derived Orthotopic Xenograft Models of Pediatric Brain Tumors: In a Mature Phase or Still in Its Infancy?
by: Eva Hermans, et al.
Published: (2020-01-01)